Simroctie A Tablet
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
You & Life Sciences Co., Ltd.
MFDS item code 202002851 · Approved 2020.04.22
This product's status changed to Approval withdrawn on 2025.02.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
This medication is used to lower total cholesterol, LDL-cholesterol, ApoB protein, and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia, and to increase HDL-cholesterol levels. It is particularly administered as an adjunct to diet in patients with heterozygous familial and non-familial hypercholesterolemia. In patients with homozygous familial hypercholesterolemia, it may be used as an adjunct or alternative therapy to other lipid-lowering treatments. It should be used in conjunction with appropriate dietary adjustments, particularly in cases where diet alone is insufficient. Before treatment, other causes of dyslipidemia, such as diabetes and hypothyroidism, should be identified and treated if necessary. Thus, this drug is helpful in improving hypercholesterolemia and reducing the risk of atherosclerotic vascular diseases.
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL-cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, regardless of meals. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL-cholesterol reduction may start with 10/10mg once daily. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and then adjust the dose. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have been taking 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see section 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily, administered in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, administration of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section 5. General Precautions, Patients with abnormal liver function under Precautions for Use). Administration in patients with renal impairment and patients with chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use caution and monitor closely when administering higher doses of this medicine to these patients (see section 5. General Precautions under Precautions for Use). Administration in elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other drugs (See section 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.
This medication carries a risk of muscle-related abnormalities, so if muscle pain or weakness occurs, it should be reported to a doctor immediately. Particularly, the risk of myopathy or rhabdomyolysis may increase when taking high doses or in combination with certain medications, so caution is required. It should not be taken by individuals with an allergy to any component of this medication, severe liver dysfunction, or ongoing unexplained elevations in liver enzyme levels. Pregnant or breastfeeding women should not take this medication, and women of childbearing age must confirm pregnancy before use. The risk of side effects may increase when this medication is taken in combination with certain powerful drugs, so if you are currently taking any medications, you must inform your doctor or pharmacist. Elderly patients or those with reduced kidney function should also exercise special caution when taking this medication. This drug may affect liver function, so it is advisable to conduct liver function tests before and during treatment regularly. Additionally, if unexplained muscle pain or weakness persists during the use of this medication, consult your healthcare provider immediately. This medication may raise blood glucose levels, so patients at risk for diabetes should regularly check their blood glucose. When starting or stopping any new medication while using this drug, always consult with medical personnel, and in case of overdose, visit a hospital immediately for proper treatment. This medicine is not recommended for children and adolescents, especially those under 10 years of age, and must be used under the guidance of a specialist.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is advisable to maintain room temperature between 1 and 30 degrees Celsius.
White to pale yellow, biconvex, rectangular tablet.
30 tablets/PTP[(10 tablets/PTP ×3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
You & Life Sciences Co., Ltd.
CombinationSimvastatin 10mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 20mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 40mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Suhung Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Seohung Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.